Scarica l'app Stockscreener
4.61
0.65%
-0.03
Dopo l'orario di chiusura:
4.61
Precedente Chiudi:
$4.64
Aprire:
$4.65
Volume 24 ore:
334.74K
Relative Volume:
0.71
Capitalizzazione di mercato:
$272.40M
Reddito:
$192.64M
Utile/perdita netta:
$2.51M
Rapporto P/E:
87.98
EPS:
0.0524
Flusso di cassa netto:
$12.42M
1 W Prestazione:
-2.54%
1M Prestazione:
+9.50%
6M Prestazione:
-10.14%
1 anno Prestazione:
-9.25%
Intervallo 1D:
$4.565
$4.71
Intervallo di 1 settimana:
$4.54
$4.92
Portata 52W:
$3.8092
$5.545
Vanda Pharmaceuticals Inc Stock (VNDA) Company Profile
Nome
Vanda Pharmaceuticals Inc
Settore
Industria
Telefono
202-734-3400
Indirizzo
2200 PENNSYLVANIA AVE NW, WASHINGTON
Confronta VNDA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VNDA
Vanda Pharmaceuticals Inc
|
4.61 | 274.17M | 192.64M | 2.51M | 12.42M | 0.0524 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Vanda Pharmaceuticals Inc Stock (VNDA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-31 | Iniziato | H.C. Wainwright | Buy |
| 2024-07-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-02-25 | Downgrade | Jefferies | Buy → Hold |
| 2021-05-12 | Iniziato | BofA Securities | Buy |
| 2021-01-14 | Downgrade | Citigroup | Buy → Neutral |
| 2020-10-29 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-06-09 | Downgrade | Citigroup | Buy → Neutral |
| 2020-03-16 | Downgrade | Oppenheimer | Perform → Underperform |
| 2020-03-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-11-07 | Downgrade | Citigroup | Buy → Neutral |
| 2019-08-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-07-25 | Downgrade | Stifel | Buy → Hold |
| 2018-12-11 | Downgrade | Oppenheimer | Outperform → Perform |
| 2018-12-04 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2018-12-04 | Reiterato | Jefferies | Buy |
| 2018-11-08 | Ripresa | Jefferies | Buy |
| 2018-09-21 | Ripresa | Oppenheimer | Outperform |
| 2018-05-23 | Iniziato | Citigroup | Buy |
| 2018-01-19 | Iniziato | Seaport Global Securities | Buy |
| 2017-09-14 | Reiterato | Piper Jaffray | Overweight |
| 2017-06-27 | Ripresa | Piper Jaffray | Overweight |
| 2017-05-26 | Iniziato | H.C. Wainwright | Buy |
| 2017-04-12 | Iniziato | Oppenheimer | Outperform |
| 2016-11-09 | Iniziato | Aegis Capital | Buy |
| 2016-10-06 | Ripresa | Jefferies | Buy |
Mostra tutto
Vanda Pharmaceuticals Inc Borsa (VNDA) Ultime notizie
Vanda Pharmaceuticals gets FDA orphan drug status for VGT-1849B - MSN
Vanda Pharmaceuticals Inc. stock daily chart insightsJuly 2025 Decliners & Real-Time Market Sentiment Alerts - Newser
Multi asset correlation models including Vanda Pharmaceuticals Inc.July 2025 Short Interest & AI Enhanced Trade Execution Alerts - Newser
Will Vanda Pharmaceuticals Inc. benefit from rate cuts2025 Growth vs Value & Fast Entry and Exit Trade Plans - خودرو بانک
Technical analysis overview for Vanda Pharmaceuticals Inc. stockWeekly Trade Report & Weekly Breakout Stock Alerts - Newser
Trend analysis for Vanda Pharmaceuticals Inc. this weekBond Market & Weekly Momentum Stock Picks - Newser
Vanda Pharmaceuticals Inc. stock trend outlook and recovery pathJuly 2025 EndofMonth & Real-Time Volume Triggers - Newser
Can Vanda Pharmaceuticals Inc. lead its sector in growthJuly 2025 Rallies & Verified Entry Point Signals - خودرو بانک
How to read the order book for Vanda Pharmaceuticals Inc.Risk Management & Free Community Consensus Stock Picks - Newser
What the charts say about Vanda Pharmaceuticals Inc. todayJuly 2025 Update & High Accuracy Swing Entry Alerts - Newser
Vanda Pharmaceuticals at Wells Fargo Conference: Strategic Growth and Innovation - Investing.com Australia
Why Vanda Pharmaceuticals Inc. is moving today2025 Price Targets & Free Real-Time Volume Trigger Notifications - Newser
Breakout Zone: What is Vanda Pharmaceuticals Inc.’s book value per shareTrade Exit Summary & Long-Term Capital Growth Ideas - خودرو بانک
How to build a dashboard for Vanda Pharmaceuticals Inc. stockEarnings Summary Report & Daily Momentum Trading Reports - Newser
Technical signs of recovery in Vanda Pharmaceuticals Inc.2025 Trading Recap & Fast Gaining Stock Strategy Reports - Newser
How institutional ownership impacts Vanda Pharmaceuticals Inc. stock2025 Sector Review & Safe Capital Preservation Plans - Newser
Is Vanda Pharmaceuticals Inc. stock poised for growthWeekly Volume Report & Low Risk Entry Point Tips - Newser
Regression analysis insights on Vanda Pharmaceuticals Inc. performancePortfolio Value Report & Expert Approved Momentum Ideas - Newser
Is Vanda Pharmaceuticals Inc. stock showing strong momentum2025 Technical Patterns & Detailed Earnings Play Strategies - خودرو بانک
Published on: 2025-09-03 23:56:45 - Newser
Vanda at Cantor Global: Strategic Growth Amid Challenges - Investing.com
Will Vanda Pharmaceuticals Inc. price bounce be sustainablePortfolio Performance Report & Verified Chart Pattern Signals - Newser
Heatmap analysis for Vanda Pharmaceuticals Inc. and competitorsJuly 2025 Market Mood & Fast Exit Strategy with Risk Control - Newser
Should you wait for a breakout in Vanda Pharmaceuticals Inc.2025 Key Highlights & High Conviction Investment Ideas - Newser
What does recent volatility data suggest for Vanda Pharmaceuticals Inc.Portfolio Risk Summary & Verified Entry Point Signals - Newser
Key metrics from Vanda Pharmaceuticals Inc.’s quarterly dataWeekly Stock Report & Momentum Based Trading Ideas - Newser
Is Vanda Pharmaceuticals Inc. reversing from oversold territoryForecast Cut & Expert Curated Trade Ideas - Newser
Is a relief rally coming for Vanda Pharmaceuticals Inc. holdersPortfolio Growth Summary & Weekly Top Gainers Alerts - Newser
Using Bollinger Bands to evaluate Vanda Pharmaceuticals Inc.Trade Performance Summary & Fast Exit and Entry Strategy Plans - Newser
Can Vanda Pharmaceuticals Inc. benefit from deglobalizationWeekly Stock Analysis & Expert Verified Stock Movement Alerts - خودرو بانک
Portfolio Update: Is Vanda Pharmaceuticals Inc. a play on infrastructure spending2025 Price Momentum & Daily Stock Trend Watchlist - خودرو بانک
Tools to assess Vanda Pharmaceuticals Inc.’s risk profile2025 Market Outlook & Verified Swing Trading Watchlist - Newser
Using fundamentals and technicals on Vanda Pharmaceuticals Inc.Share Buyback & Capital Protection Trading Alerts - Newser
Why is Vanda Pharmaceuticals Inc. stock going upJuly 2025 Intraday Action & Weekly Sector Rotation Insights - خودرو بانک
Order Flow Trends Show Accumulation in Vanda Pharmaceuticals Inc.Weekly Profit Report & Consistent Growth Equity Picks - beatles.ru
Vanda Pharmaceuticals Inc Azioni (VNDA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):